Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mary Ellen Ross"'
Publikováno v:
J Psychoactive Drugs
One hundred twenty one opiate-dependent individuals in methadone maintenance treatment at an urban university medical center in the U.S. were administered the Inventory of Drug Use Consequences (InDUC), and 68 subjects provided follow-up assessments
Autor:
Patrick J. Creaven, Lakshmi Pendyala, Vladimir Badmaev, Mary Ellen Ross, Patrick F. Smith, Marwan Fakih, Joshua Prey, William E. Brady, Youcef M. Rustum
Publikováno v:
Cancer Chemotherapy and Pharmacology. 62:499-508
We conducted a phase I study to determine the recommended dose of selenomethionine (SLM) in combination with irinotecan that consistently results in a protective plasma selenium (Se) concentrations15 microM after 1 week of SLM loading.A 3-3 standard
Autor:
Mary Ellen Ross, Michael A. Caligiuri
Publikováno v:
Blood. 89:910-918
Interferon-γ (IFN-γ) is critical for an effective innate immune response against infection. A combination of interleukins (ILs) derived from activated T cells (IL-2) and monocytes (IL-12), or monocytes alone (IL-15 and IL-12), induces optimal produ
Autor:
L Sullivan, Chuan-Chu Chou, MV Seiden, Robert A. Baiocchi, S Haldar, M Monne, Mary Ellen Ross, J Sklar, SK Narula, Jian Tan
Publikováno v:
Blood. 85:1063-1074
Both human (hu) and viral (v) interleukin-10 (IL-10) appear to be important cofactors in the survival and growth of lymphoblastoid cell lines infected with Epstein-Barr virus (EBV). When mice with severe combined immune deficiency (SCID) are injected
Autor:
Mary Ellen Ross
Publikováno v:
Neophilologus. 76:41-50
Autor:
Marwan Fakih, Karoli Toth, Lakshmi Pendyala, Alan Litwin, Julianne L. Holleran, Gerald J. Fetterly, Igor Espinoza-Delgado, Youcef M. Rustum, Merrill J. Egorin, James A. Zwiebel, Mary Ellen Ross
Purpose: We conducted a phase I study to determine the maximum tolerated dose of vorinostat in combination with fixed doses of 5-fluorouracil (FU), leucovorin, and oxaliplatin (FOLFOX). Experimental Design: Vorinostat was given orally twice daily for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a676a7b68b17abbe3bd4392d9c4375a
https://europepmc.org/articles/PMC4134938/
https://europepmc.org/articles/PMC4134938/
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1078:360-368
In an earlier publication (Harvey, et al. (1982) J. Biol. Chem., 257, 5645–5651) the discovery of a family of unusually large molecules with plasminogen activator activity in the conditioned medium of a human lung cancer cell line was reported. The
Autor:
Ajithkumar Puthillath, Michelle Wisniewski, Mary Ellen Ross, Nikhil I. Khushalani, Marwan Fakih, Karen Romano, Lynn M. Steinbrenner, Gregory E. Wilding, Terry Mashtare
Publikováno v:
Critical reviews in oncology/hematology. 71(3)
Purpose This phase II study was conducted to determine the efficacy and safety of capecitabine and bevacizumab in untreated elderly metastatic colorectal cancer patients. Methods Patients received 1500 mg/m 2 /dose of capecitabine twice daily × 7 da
Autor:
Marwan Fakih, Ashwani Rajput, Chris Andrews, Karoly Toth, Charles LeVea, Lakshmi Pendyala, Gary Y. Yang, Youcef M. Rustum, Kelli M. BullardDunn, Ajithkumar Puthillath, Young-Mee Park, Mary Ellen Ross
Publikováno v:
International journal of radiation oncology, biology, physics. 72(3)
Purpose To evaluate the efficacy of a combination of capecitabine, oxaliplatin, and radiotherapy (RT) in the neoadjuvant treatment of Stage II and III rectal cancers. Methods Capecitabine was given at 725 mg/m 2 orally twice daily Monday through Frid
Publikováno v:
Clinical colorectal cancer. 6(8)
Background Uridine diphosphate glucuronosyltransferase (UGT) 1A1 7/7 polymorphism has been linked with an increased risk of irinotecan-induced severe toxicities. We evaluated UGT1A1 polymorphism in patients developing grade 3/4 toxicity after initiat